Bio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail Partners.
The new funding will be used to accelerate product development, improve customer service capacities, and boost sales and marketing efforts, according to the company.
“Our business is founded on...
